vs
Side-by-side financial comparison of IDEX Corporation (IEX) and Natera, Inc. (NTRA). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($899.1M vs $665.5M, roughly 1.4× Natera, Inc.). IDEX Corporation runs the higher net margin — 14.3% vs 7.1%, a 7.2% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (376.5% vs 39.8%). IDEX Corporation produced more free cash flow last quarter ($189.8M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 5.5%).
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
IEX vs NTRA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $899.1M | $665.5M |
| Net Profit | $128.3M | $47.3M |
| Gross Margin | 43.1% | — |
| Operating Margin | 20.4% | -3.4% |
| Net Margin | 14.3% | 7.1% |
| Revenue YoY | 376.5% | 39.8% |
| Net Profit YoY | 688.5% | 187.9% |
| EPS (diluted) | $1.71 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $899.1M | — | ||
| Q4 25 | $899.1M | $665.5M | ||
| Q3 25 | $878.7M | $592.2M | ||
| Q2 25 | $865.4M | $546.6M | ||
| Q1 25 | $814.3M | $501.8M | ||
| Q4 24 | $862.9M | $476.1M | ||
| Q3 24 | $798.2M | $439.8M | ||
| Q2 24 | $807.2M | $413.4M |
| Q1 26 | $128.3M | — | ||
| Q4 25 | $128.3M | $47.3M | ||
| Q3 25 | $127.8M | $-87.5M | ||
| Q2 25 | $131.6M | $-100.9M | ||
| Q1 25 | $95.5M | $-66.9M | ||
| Q4 24 | $123.2M | $-53.8M | ||
| Q3 24 | $119.1M | $-31.6M | ||
| Q2 24 | $141.3M | $-37.5M |
| Q1 26 | 43.1% | — | ||
| Q4 25 | 43.1% | — | ||
| Q3 25 | 44.5% | — | ||
| Q2 25 | 45.3% | — | ||
| Q1 25 | 45.3% | — | ||
| Q4 24 | 42.5% | — | ||
| Q3 24 | 44.3% | — | ||
| Q2 24 | 45.4% | — |
| Q1 26 | 20.4% | — | ||
| Q4 25 | 20.4% | -3.4% | ||
| Q3 25 | 21.1% | -16.5% | ||
| Q2 25 | 21.7% | -20.2% | ||
| Q1 25 | 17.4% | -15.8% | ||
| Q4 24 | 19.2% | -13.6% | ||
| Q3 24 | 21.0% | -8.9% | ||
| Q2 24 | 22.6% | -10.6% |
| Q1 26 | 14.3% | — | ||
| Q4 25 | 14.3% | 7.1% | ||
| Q3 25 | 14.5% | -14.8% | ||
| Q2 25 | 15.2% | -18.5% | ||
| Q1 25 | 11.7% | -13.3% | ||
| Q4 24 | 14.3% | -11.3% | ||
| Q3 24 | 14.9% | -7.2% | ||
| Q2 24 | 17.5% | -9.1% |
| Q1 26 | $1.71 | — | ||
| Q4 25 | $1.71 | $0.36 | ||
| Q3 25 | $1.70 | $-0.64 | ||
| Q2 25 | $1.74 | $-0.74 | ||
| Q1 25 | $1.26 | $-0.50 | ||
| Q4 24 | $1.61 | $-0.41 | ||
| Q3 24 | $1.57 | $-0.26 | ||
| Q2 24 | $1.86 | $-0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $580.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.0B | $1.7B |
| Total Assets | $6.9B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $580.0M | — | ||
| Q4 25 | $580.0M | — | ||
| Q3 25 | $593.8M | $1.0M | ||
| Q2 25 | $568.2M | $16.0M | ||
| Q1 25 | $594.1M | $17.8M | ||
| Q4 24 | $620.8M | $22.7M | ||
| Q3 24 | $633.2M | $29.5M | ||
| Q2 24 | $700.7M | $90.3M |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | $4.0B | — | ||
| Q4 25 | $4.0B | $1.7B | ||
| Q3 25 | $4.0B | $1.3B | ||
| Q2 25 | $4.0B | $1.2B | ||
| Q1 25 | $3.9B | $1.2B | ||
| Q4 24 | $3.8B | $1.2B | ||
| Q3 24 | $3.8B | $878.5M | ||
| Q2 24 | $3.7B | $836.5M |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.9B | $2.4B | ||
| Q3 25 | $7.0B | $1.8B | ||
| Q2 25 | $6.9B | $1.8B | ||
| Q1 25 | $6.8B | $1.7B | ||
| Q4 24 | $6.7B | $1.7B | ||
| Q3 24 | $7.0B | $1.6B | ||
| Q2 24 | $5.9B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $73.9M |
| Free Cash FlowOCF − Capex | $189.8M | $37.8M |
| FCF MarginFCF / Revenue | 21.1% | 5.7% |
| Capex IntensityCapex / Revenue | 7.1% | 5.4% |
| Cash ConversionOCF / Net Profit | — | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | $715.2M | $109.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $209.5M | $73.9M | ||
| Q3 25 | $203.5M | $59.4M | ||
| Q2 25 | $161.7M | $37.6M | ||
| Q1 25 | $105.7M | $44.5M | ||
| Q4 24 | $172.6M | $52.9M | ||
| Q3 24 | $205.3M | $51.8M | ||
| Q2 24 | $133.6M | $4.0M |
| Q1 26 | $189.8M | — | ||
| Q4 25 | $189.8M | $37.8M | ||
| Q3 25 | $188.7M | $37.0M | ||
| Q2 25 | $146.9M | $11.7M | ||
| Q1 25 | $91.4M | $22.6M | ||
| Q4 24 | $157.1M | $34.8M | ||
| Q3 24 | $191.6M | $35.5M | ||
| Q2 24 | $117.7M | $-7.7M |
| Q1 26 | 21.1% | — | ||
| Q4 25 | 21.1% | 5.7% | ||
| Q3 25 | 21.5% | 6.2% | ||
| Q2 25 | 17.0% | 2.1% | ||
| Q1 25 | 11.2% | 4.5% | ||
| Q4 24 | 18.2% | 7.3% | ||
| Q3 24 | 24.0% | 8.1% | ||
| Q2 24 | 14.6% | -1.9% |
| Q1 26 | 7.1% | — | ||
| Q4 25 | 2.2% | 5.4% | ||
| Q3 25 | 1.7% | 3.8% | ||
| Q2 25 | 1.7% | 4.7% | ||
| Q1 25 | 1.8% | 4.3% | ||
| Q4 24 | 1.8% | 3.8% | ||
| Q3 24 | 1.7% | 3.7% | ||
| Q2 24 | 2.0% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.63× | 1.56× | ||
| Q3 25 | 1.59× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.11× | — | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.72× | — | ||
| Q2 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
